NCT05964868
Efficacy of Liposomal Bupivacaine Post Septorhinoplasty
Enrolling by Invitation
PHASE3Ages 18–99InterventionalTreatmentJessyka LighthallInvestigator-initiated
~72 participants
Updated 2026-04-03 on ClinicalTrials.gov
What's tested:Liposomal Bupivacaine0.25% bupivacaine with 1:200,000 epinephrinePlacebo - Saline solution
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Differences in postoperative milligram morphine equivalents (MME) used between placebo and liposomal bupivacaine
Measured over 6 months
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Jessyka Lighthall, MD · PRINCIPAL_INVESTIGATOR · Penn State Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Differences in postoperative milligram morphine equivalents (MME) used between placebo and liposomal bupivacaine6 months
Convert amount of opioid ingested to MMEs as an objective measure of post-operative narcotic use